ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,112Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 487

$784K Total Retail Price of All Prescriptions

Rank: 7 out of 487

676 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 676 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 676 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 12,779 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
OMEPRAZOLE 642 596 1 2
LEVOTHYROXINE SODIUM 569 495 2 1
HYDROCODONE-ACETAMINOPHEN 523 427 S3 3 3
SIMVASTATIN 370 334 4 4
POTASSIUM CHLORIDE 322 288 5 10
LISINOPRIL 316 290 6 5
WARFARIN SODIUM 309 286 7 11
FUROSEMIDE 303 256 8 7
GABAPENTIN 298 240 9 13
METOPROLOL TARTRATE 271 267 10 17
AZITHROMYCIN 267 212 11 50
ZOLPIDEM TARTRATE 262 212 12 14
TRIAMTERENE-HCTZ 254 246 13 49
CITALOPRAM HBR 201 135 14 12
TRAMADOL HCL 191 166 15 19
METOPROLOL SUCCINATE 190 156 16 15
METFORMIN HCL 185 163 17 8
DIGOXIN 183 170 18 47
TRIAMTERENE-HYDROCHLOROTHIAZID 183 176 18 122
LOSARTAN POTASSIUM 182 173 20 16
NEXIUM 177 124 21 41
MELOXICAM 172 129 22 26
AMLODIPINE BESYLATE 159 156 23 6
ALLOPURINOL 155 125 24 29
AMITRIPTYLINE HCL 154 104 R 25 45
SPIRONOLACTONE 132 119 26 43
SYNTHROID 128 110 27 87
FENTANYL 127 110 S2 28 36
FLUOXETINE HCL 125 89 29 28
VERAPAMIL ER 120 110 30 114
PREDNISONE 120 98 30 37
TAMSULOSIN HCL 118 115 32 25
CELEBREX 117 117 33 103
ALENDRONATE SODIUM 108 108 34 27
ROPINIROLE HCL 107 106 35 60
METHYLPREDNISOLONE 106 92 36 157
AMIODARONE HCL 103 103 37 201
CARVEDILOL 100 98 38 32
FENOFIBRATE 100 94 38 61
LANTUS SOLOSTAR 90 85 40 72
FLUTICASONE PROPIONATE 87 61 41 33
POLYETHYLENE GLYCOL 3350 86 86 42 56
MORPHINE SULFATE ER 85 22 S2 43 54
IBUPROFEN 85 45 43 78
OXYBUTYNIN CHLORIDE 85 64 43 99
LANTUS 85 83 43 44
GLYBURIDE 84 81 R 47 132
CIPROFLOXACIN HCL 82 73 48 66
TRAZODONE HCL 80 59 49 22
HYDROCHLOROTHIAZIDE 80 80 49 9
ENDOCET 80 58 S2 49 187
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 70 52 90
CYMBALTA 72 50 53 34
LYRICA 72 43 53 77
CLOTRIMAZOLE-BETAMETHASONE 71 58 55 158
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 52 56 24
ACTOS 68 52 56 88
SERTRALINE HCL 67 61 58 21
AMOXICILLIN 64 58 59 173
NAMENDA 64 64 59 53
ATORVASTATIN CALCIUM 63 61 61 18
DILTIAZEM 24HR ER 63 63 61 179
METFORMIN HCL ER 62 56 63 31
AMOX TR-POTASSIUM CLAVULANATE 62 54 63 124
CARBIDOPA-LEVODOPA 62 62 63 85
PANTOPRAZOLE SODIUM 62 62 63 62
OXYCODONE HCL 60 42 S2 67 57
VENTOLIN HFA 59 45 68 140
JANUVIA 59 58 68 99
PHENYTOIN SODIUM EXTENDED 57 33 70 160
GLIMEPIRIDE 56 53 71 35
CEPHALEXIN 55 39 72 108
LANSOPRAZOLE 55 29 72 153
FINASTERIDE 54 54 74 105
CLOPIDOGREL 51 51 75 91
SINGULAIR 51 39 75 125
ESTRADIOL 51 36 R 75 68
BENAZEPRIL HCL 51 51 75 67
METHOTREXATE 51 42 75 255
GLIPIZIDE 50 37 80 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.